IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
IKKβ in intestinal mesenchymal cells promotes initiation of colitis-associated cancer
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 212, Issue 13, Pages 2235-2251
Publisher
Rockefeller University Press
Online
2015-12-01
DOI
10.1084/jem.20150542
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IKKβ acts as a tumor suppressor in cancer-associated fibroblasts during intestinal tumorigenesis
- (2015) Charles K. Pallangyo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Epimorphin−/− mice are protected, in part, from acute colitis via decreased interleukin 6 signaling
- (2014) Anisa Shaker et al. Translational Research
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- IKK biology
- (2012) Fei Liu et al. IMMUNOLOGICAL REVIEWS
- NF-κB and the link between inflammation and cancer
- (2012) Joseph A. DiDonato et al. IMMUNOLOGICAL REVIEWS
- Tpl2 regulates intestinal myofibroblast HGF release to suppress colitis-associated tumorigenesis
- (2012) Vasiliki Koliaraki et al. JOURNAL OF CLINICAL INVESTIGATION
- From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation
- (2012) Charlotte Servais et al. JOURNAL OF PATHOLOGY
- Intestinal myofibroblasts: targets for stem cell therapy
- (2011) R. C. Mifflin et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
- (2011) S. Normand et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner
- (2010) Neta Erez et al. CANCER CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis
- (2010) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- gp130-Mediated Stat3 Activation in Enterocytes Regulates Cell Survival and Cell-Cycle Progression during Colitis-Associated Tumorigenesis
- (2009) Julia Bollrath et al. CANCER CELL
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
- (2009) Sergei Grivennikov et al. CANCER CELL
- Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors
- (2009) Masayuki Fukata et al. INFLAMMATORY BOWEL DISEASES
- Effectiveness of IκB kinase inhibitors in murine colitis-associated tumorigenesis
- (2009) Yoku Hayakawa et al. JOURNAL OF GASTROENTEROLOGY
- Pten in stromal fibroblasts suppresses mammary epithelial tumours
- (2009) Anthony J. Trimboli et al. NATURE
- Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
- (2008) Maria Armaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Opposing functions of IKK during acute and chronic intestinal inflammation
- (2008) L. Eckmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started